Blood in stools
Visible blood, or stools that appear dark — always warrants investigation.
Colorectal cancer is the most common cancer in Singaporean men and the second most common in women — yet it typically develops slowly from screen-detectable polyps. AARO provides the radiation component of colorectal care: chemoradiation for rectal cancer, and SBRT for liver and lung oligometastases.
Colorectal cancer is the uncontrolled growth of cells in the colon or rectum. Most begin as polyps — growths on the inner lining of the large intestine. Adenomatous polyps (adenomas) can transform into cancer over many years, which is exactly why screening and polyp removal prevent cancer, not just detect it.
The great majority of colorectal cancers are adenocarcinomas, beginning in the mucus-producing cells of the intestinal lining. Rarer types include carcinoid tumours, gastrointestinal stromal tumours, lymphomas and sarcomas.
If a polyp becomes cancerous, the cancer invades through the layers of the bowel wall over time. Once it reaches blood or lymph vessels, it can travel to nearby lymph nodes or to other organs — most commonly the liver and lungs, where modern SBRT gives radiation a new curative-intent role.
Early colorectal cancer often causes few or no symptoms — which is why screening from age 50 matters. Later, these signs may appear:
Visible blood, or stools that appear dark — always warrants investigation.
Diarrhoea, constipation, or a change in stool consistency that persists.
Persistent abdominal pain, cramping or discomfort.
Unexplained anaemia, weakness or fatigue — often from slow, unseen blood loss.
A mass you or your doctor can feel.
Losing weight without trying.
Colonoscopy remains the gold standard — it finds cancer, and removes the polyps that would have become cancer.
From age 50 (earlier with family history): stool-based FIT testing, or colonoscopy as the definitive screen.
Direct visualisation of the colon and rectum; suspicious lesions are biopsied and polyps removed at the same sitting.
CT of the chest, abdomen and pelvis — plus MRI for rectal cancers — establishes local extent and any spread.
Tumour markers (CEA) and molecular profiling guide systemic therapy decisions.
Most patients are over 50 — but risk factors below shift both risk and the age screening should start.
Most colorectal cancers are diagnosed after 50 — the anchor for screening guidelines.
A blood relative with colorectal cancer, or a personal history of cancer or polyps.
Familial adenomatous polyposis (FAP) and Lynch syndrome dramatically raise risk and warrant early surveillance.
Ulcerative colitis and Crohn's disease raise long-term risk.
Low-fibre, high-fat diets, obesity and inactivity contribute to risk.
Diabetes is independently associated with higher colorectal cancer risk.
Surgery is the backbone of colorectal treatment — with radiation playing defined, evidence-based roles before rectal surgery and against limited metastatic disease.
Radiation with chemotherapy before surgery shrinks rectal tumours, improves local control and can enable sphincter-preserving surgery.
Ablative radiation for limited liver or lung metastases — treating each deposit precisely, in a handful of sessions.
Modern intensity-modulated delivery keeps bowel and bladder dose low across every pelvic course.
Chemotherapy and targeted therapy sequenced with radiation and surgery in one multidisciplinary plan.
Every plan at AARO goes through detailed contouring, dose simulation, and independent physics review before a single beam is delivered. We do this so the radiation hits exactly the tissue that needs it — and avoids the healthy tissue around it.
Our medical physicists and radiation therapists collaborate on each plan — contouring tumour and organs-at-risk, simulating dose distribution, and independently checking every parameter before delivery.
Imaging before each fraction confirms the target's position to the millimetre — so tight margins stay safe, and healthy tissue stays out of the high-dose region.
Each treatment session takes 15–30 minutes. You'll lie on a precision treatment couch beneath the linear accelerator. Positioning lasers and daily imaging align you to within a millimetre of the planned position.
You won't feel the radiation as it's delivered. There's no anaesthesia, no recovery time, and no overnight stay. Most patients drive themselves home after the session and return to normal activities the same day.
Colorectal radiation at AARO is delivered by sub-specialists in gastrointestinal cancers and SBRT — including internationally published expertise in rectal cancer chemoradiation.
Book a 45–60 minute specialist consultation. We'll review your imaging and pathology, explain the options that apply to your case, and answer your questions.